Neuromusculoskeletal Health in Pediatric Obesity: Incorporating Evidence into Clinical Examination

Grace C O'Malley1,2, Sarah P Shultz3, David Thivel4

  • 1School of Physiotherapy, Division of Population Health Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland. graceomalley@rcsi.ie.

Current Obesity Reports
|December 27, 2021
PubMed

Insights

Children with obesity often have neuromusculoskeletal impairments affecting movement and physical activity. Early assessment and tailored management are crucial for their overall health and weight management.

Area of Science:

  • Pediatric obesity
  • Neuromusculoskeletal health
  • Physical activity

Background:

  • Children with obesity frequently experience neuromusculoskeletal impairments.
  • These impairments can lead to pain, reduced strength, balance issues, and altered gait.
  • Neuromusculoskeletal health is integral to a child's movement, physical activity engagement, and overall development.

Purpose of the Study:

  • To emphasize the clinical significance of assessing and managing neuromusculoskeletal health in pediatric obesity.
  • To promote the integration of evidence-based practices into clinical settings for managing pediatric obesity.
  • To support healthcare professionals in optimizing obesity treatment through neuromusculoskeletal care.

Main Methods:

  • Review of current evidence on neuromusculoskeletal health in pediatric obesity.
  • Analysis of the impact of impairments on physical activity and development.
  • Guidance on screening, assessment, and intervention strategies.

Main Results:

  • Children with obesity commonly exhibit neuromusculoskeletal impairments, including pain, weakness, and balance deficits.
  • These impairments significantly affect motor skills, gait, posture, and fatigue levels.
  • Addressing neuromusculoskeletal issues is vital to minimize movement barriers and encourage physical activity.

Conclusions:

  • Screening for and managing neuromusculoskeletal impairments should be a standard part of pediatric obesity care.
  • Personalized interventions and modified exercise programs are necessary for effective obesity treatment.
  • Further research is needed to understand the bidirectional relationship between neuromusculoskeletal health and obesity treatment outcomes.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
675
Assessment of Airway, Skin Color, and Use of Accessory Muscles01:30

Assessment of Airway, Skin Color, and Use of Accessory Muscles

A thorough assessment of respiratory health is paramount in clinical settings to identify and manage respiratory distress and ensure adequate oxygenation. This article elaborates on the critical aspects of respiratory evaluation, including airway assessment, skin color examination, and the observation of accessory muscle use, which are integral to effectively diagnosing and managing patients with respiratory conditions.
Introduction
The initial evaluation of a patient's respiratory system...
1.2K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
9
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
7
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.2K
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
2.7K